arrow
K

Kelvin Chan

University of Toronto
H指数:60
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti–HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial

替诺福韦艾拉酚胺用于预防HBsAg阴性、抗-HBc阳性患者接受利妥昔单抗为基础化疗时HBV再激活:一项多中心随机对照试验

2025-12-030
OAAI
Opportunistic screening for broad range of medically relevant secondary findings: Laboratory benefits and burdens

机会性筛查对广泛相关的临床二级发现的实验室效益与负担

2025-10-140
OAAI
Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi process

关于癌症诊断到治疗间隔与总生存期关联性研究的建议:一项改良德尔菲过程

2025-09-050
OAAI
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
Real-world comparative effectiveness and safety of Pertuzumab in patients with HER2+metastatic breast cancer: A pan-Canadian population-based cohort study

帕妥珠单抗治疗HER2转移性乳腺癌患者的真实世界疗效和安全性比较: 一项泛加拿大人群队列研究

2025-04-010
OAAI